Standout Papers

Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma 2007 2026 2013 2019 4.4k
  1. Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma (2007)
    Robert J. Motzer, Thomas E. Hutson et al. New England Journal of Medicine

Immediate Impact

9 by Nobel laureates 6 from Science/Nature 112 standout
Sub-graph 1 of 14

Citing Papers

From geroscience to precision geromedicine: Understanding and managing aging
2025 Standout
Cabozantinib plus Nivolumab and Ipilimumab in Renal-Cell Carcinoma
2023 Standout

Works of Paul Bycott being referenced

Practical Considerations and Recommendations for Master Protocol Framework: Basket, Umbrella and Platform Trials
2021
Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma
2007 Standout

Author Peers

Author Last Decade Papers Cites
Paul Bycott 4423 2909 2177 3694 50 7.0k
Isan Chen 6901 3565 3054 4715 41 8.9k
Tomasz Demkow 4227 2139 2280 3567 76 6.5k
Apurva A. Desai 3973 2426 2169 3863 35 6.7k
A Płużańska 8129 6183 2864 3165 65 11.4k
Minghua Shan 3946 2008 2077 3313 38 5.9k
Manuela Schmidinger 5213 2877 2197 3810 177 8.2k
Michael Siebels 3367 1580 1562 2686 64 5.2k
Robert W. Ross 3472 6050 1905 3883 61 10.9k
Glenn Liu 4737 2771 1703 2479 172 8.3k
I. Bodrogi 6343 3498 2896 4241 77 10.2k

All Works

Loading papers...

Rankless by CCL
2026